SSBP2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68872
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: LGPQSDPWLSLQNYGGAMRPPLNALGGPGMPGMNMGPGGGR
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SSBP2 Antibody
Immunocytochemistry/ Immunofluorescence: SSBP2 Antibody [NBP2-68872]
Immunocytochemistry/Immunofluorescence: SSBP2 Antibody [NBP2-68872] - Staining of human cell line SH-SY5Y shows localization to nucleoplasm & vesicles.Applications for SSBP2 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Recommended conditions: Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SSBP2
Alternate Names
DKFZp686F03273, HSPC116, Sequence-specific single-stranded-DNA-binding protein 2, single-stranded DNA binding protein 2, single-stranded DNA-binding protein 2, SOSS-B2, SSDP2
Gene Symbol
SSBP2
Additional SSBP2 Products
Product Documents for SSBP2 Antibody
Product Specific Notices for SSBP2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...